سعر ديورافوس امبول 2 مل حقن عضل أو داخل المفصل 2024

Durafos 1 amp. 2ml im or intra articular — Betamethasone dipropionate + betamethasone sodium phosphate (Sigma Tec > Eva Pharma).

• Corticosteroid-responsive inflammatory, allergic and rheumatic conditions suitable for IM or intra-articular glucocorticoid injection — as for betamethasone dipropionate/sodium phosphate injectable suspensions (e.g. Diprofos-type SmPC); confirm Egyptian indications. Directory notes anti-inflammatory use for osteoarthritis/arthritis and allergic conditions.Population: AdultsEFDA / Organon South Africa SmPC (public PDF listing)

• Systemic fungal infections; hypersensitivity to betamethasone or other corticosteroids; IV use contraindicated for this suspension type; do not inject into unstable joints or infected sites — see full Diprofos-type SmPC (partially verified).International label, equivalent formulation · EFDA / Organon South Africa SmPC (public PDF listing)

• Adrenal suppression, infection risk, hyperglycemia, mood changes, osteoporosis with repeated systemic steroids. Intra-articular injection: risk of joint damage if repeated improperly. Not for IV or SC use for dipropionate/phosphate suspension products (class SmPC).International label, equivalent formulation · EFDA / Organon South Africa SmPC (public PDF listing)

• Systemic corticosteroids may cause fetal harm; use in pregnancy only if potential benefit justifies risk — consult Egyptian SmPC (ingredient-level).General active-ingredient information · WHO Collaborating Centre for Drug Statistics Methodology

• Betamethasone dipropionate: Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions via intracellular glucocorticoid receptor-mediated gene regulation of inflammatory mediators. Percutaneous absorption increases with inflammation and occlusion.
• Betamethasone sodium phosphate: Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions via intracellular glucocorticoid receptor-mediated gene regulation of inflammatory mediators. Percutaneous absorption increases with inflammation and occlusion.